|

Posters,
Presentations & Publications
For
Presentations and Posters in PDF Adobe
Acrobat Reader is required. If you experience problems downloading
the PDF, see Note in right margin, or we can send an 11x17 hard
copy to you. Please e-mail info@inspirepharm.com
with name, address, & telephone number.
2008
2007
2006 2005 2004 2003 2002 2001 2000 1996-1999
Kellerman
D, Rossi Mospan A, Engels J, Schaberg A, Gorden J, Smiley L.
Denufosol:
A review of studies with inhaled P2Y2 agonists
that led to Phase 3.
Pulm Pharmacol Ther. 2007 December 31.
Ratner
PH, Amar NJ, Hampel FC, van Bavel JH, Widmann MC, Kellerman D, Tian
W, Schaberg A. Epinastine HCl nasal spray is effective and well
tolerated for the treatment of seasonal allergic rhinitis. PowerPoint
presentation at The 2007 Annual Meeting of American College of
Allergy, Asthma, & Immunology (ACAAI). 2007 November 8-14;
Dallas, Texas, USA. Abstract
in PDF
LaVange
L, Engels J, Accurso FJ. Analyzing percent change in cystic fibrosis
clinical trials. Poster presented at The 21st Annual North
American Cystic Fibrosis Conference. 2007 October 3-6; Anaheim,
California, USA. Poster
in PDF
Mathews D, Schaberg A, Brandi V, Engels J, Gorden J, Deterding R.
Pediatric experience from three integrated phase 2 studies of
denufosol tetrasodium inhalation solution. Poster presented
at The 21st Annual North American Cystic Fibrosis Conference.
2007 October 3-6; Anaheim, California, USA. Poster
in PDF
Friedman JY, Hardy C, Dewitt EM, Schulman KA, Reed SD. Patterns
of antibiotic use for patients with mild cystic fibrosis. Poster
presented at The 21st Annual North American Cystic Fibrosis Conference.
2007 October 3-6; Anaheim, California, USA. Poster
in PDF
Thelin
W, Lazarowski E, Boyer JL, Boucher R. Denufosol
is a stable and potent inducer of airway secretion. Poster presented
at The 21st Annual North American Cystic Fibrosis Conference.
2007 October 3-6; Anaheim, California, USA. Poster
in PDF
Johnson FL, Boyer JL, Leese PT, Crean C, Krishnamoorthy R, Durham
T, Fox AW, Kellerman DJ. Rapid
and reversible modulation of platelet function in man by a novel
P2Y12 ADP-receptor antagonist, INS50589.
Platelets. 2007 August;18(5):346-356.
Deterding
RR, Lavange LM, Engels JM, Mathews DW, Coquillette SJ, Brody AS,
Millard SP, Ramsey BW; for the Cystic Fibrosis Therapeutics Development
Network and the Inspire 08-103 Working Group. Phase 2 randomized
safety and efficacy trial of nebulized denufosol tetrasodium in
cystic fibrosis. Am J Respir Crit Care Med. 2007 August
15;176(4):362-369.
Watson
PS, She J, Lampe JW, Polianski AB. The total systhesis of latrunculin
B. Poster presented at The Gordon Research Confrence on Natural
Products. 2007 July 22-27; Tilton, New Hampsire, USA.
Nichols
K, Morris S, Tian W. An evaluation of the effects of epinastine
HCl ophthalmic solution, 0.05% (Elestat®) on contact
lens comfort in subjects with contact lens intolerance during allergy
season. Poster presented at the 110th
Annual American Optometric Association (AOA) Congress Optometry's
Meeting. 2007 June 27-July 1; Boston, Massachusetts, USA.
Kellerman
D, Warren S, Rossi A, Taylor G, Smiley L. Deposition and pharmacokinetic
studies with inhaled P2Y2 agonists - Evidence
of high lung delivery and minimal systemic exposure. Poster
presented at the 30th European Cystic Fibrosis Society
(ECFS) Conference. 2007 June 13-16; Belek, Turkey. Poster
in PDF
Rossi
A, Brandi V, Engels J, Gorden J, Schaberg A, Smiley L. Reactive
airway disease and cystic fibrosis: A retrospective analysis of
the safety and tolerability with denufosol inhalation solution.
Poster presented at the 30th European Cystic Fibrosis
Society (ECFS) Conference. 2007 June 13-16; Belek, Turkey. Poster
in PDF
Wolff
SC, Brubaker K, Navratil T, Fulcher EH, Lankford JR, Boyer JL. Evaluation
of muscarinic receptor antagonism by antihistamines. Poster
presented at the XXVI European Academy of Allergology and Clinical
Immunology (EAACI) Congress. 2007 June 9-13; Göteborg,
Sweden. Poster
in PDF
Lukat
K-F, Kuna P, Sanquer F, Ivan P, Dimitrov V, Molina Gorina M, Van
De Heyning PH, Loureiro AC, the Bilastine International Working
Group, Valiente R, Sologuren A. Treatment with Bilastine improves
symptoms in patients with seasonal allergic rhinitis. Poster
presented at the XXVI European Academy of Allergology and Clinical
Immunology (EAACI) Congress. 2007 June 9-13; Göteborg,
Sweden. Poster
in PDF
Kuna
P, Nowacki Z, Van Cauwenberghe P, Lukat KF, Spicakova M, Agache
I, Fouquert L, Roger A, the Bilastine International Working Group,
Sologuren A, Valiente R. A phase 3 study comparing the efficacy
and safety of once daily Bilastine with cetirizine and placebo
for the treatment of Seasonal Allergic Rhinitis (SAR). Poster
presented at the XXVI European Academy of Allergology and Clinical
Immunology (EAACI) Congress. 2007 June 9-13; Göteborg,
Sweden. Poster
in PDF
Brazzell
R, Kellerman DJ, Schaberg A, Yerxa B,Durham T. Effect
of diquafosol on ocular surface health in dry eye disease. Poster
presented at The Association for Research in Vision and Ophthalmology
(ARVO) 2007 Annual Meeting. 2007 May 6-10; Fort Lauderdale,
Florida, USA. Poster
in PDF
Ousler
GW III, Brazzell K, Durham T, Walker P, Anderson RT, Abelson MB.
A correlation between central corneal staining and visual function
in patients diagnosed with dry eye. Poster presented at The
Association for Research in Vision and Ophthalmology (ARVO) 2007
Annual Meeting. 2007 May 6-10; Fort Lauderdale, Florida, USA.
Poster
in PDF
Wolff SC, Brubaker K, Wright RC, Boyer JL. The pharmacological
properties of epinastine on histamine H2
and H4 receptors. Poster presented at
The Association for Research in Vision and Ophthalmology (ARVO)
2007 Annual Meeting. 2007 May 6-10; Fort Lauderdale, Florida,
USA.
Bowman
LM, Si E, Pang J, Friedlaender M. Development of a commercial
eye drop formulation of azithromycin. Poster presented at The
Association for Research in Vision and Ophthalmology (ARVO) 2007
Annual Meeting. 2007 May 6-10; Fort Lauderdale, Florida, USA.
Poster
in PDF
Yates KA, Romanowski EG, Kowalski RP, Mah FS, Gordon YJ. Frequent
dosing with topical 1% azithromycin is effective in reducing azithromycin-resistant
pseudomonas aeruginosa colony counts in a NZW rabbit model.
Poster presented at The Association for Research in Vision and
Ophthalmology (ARVO) 2007 Annual Meeting. 2007 May 6-10; Fort
Lauderdale, Florida, USA.
Poster in PDF
Cowlen
M, Crean C, Poulin D, Ching S, Peterson W, Anderson S. 52-Week
inhalation toxicology study of nebulized denufosol tetrasodium in
Beagle dogs. Poster presented at the Society of Toxicology
(SOT) 46th Annual Meeting. 2007 March 25-29; Charlotte, North
Carolina, USA. Poster
in PDF
Anderson
S, Crean C, Poulin D, Ching S, Peterson W, Cowlen M. 26-Week
inhalation toxicology study of nebulized denufosol tetrasodium in
Sprague Dawley rats. Poster presented at the Society of Toxicology
(SOT) 46th Annual Meeting. 2007 March 25-29; Charlotte, North
Carolina, USA. Poster
in PDF
Wolff
SC, Brubaker K, Navratil T, Fulcher EH, Lankford JR and Boyer JL.
Anticholinergic effects of antihistamine drugs used in the clinic.
PowerPoint presentation at the American Academy of Allergy, Asthma
& Immunology (AAAAI) 2007 Annual Meeting. 2007 February
23-27; San Diego, California, USA. Presentation
in PDF
Page
last updated: 23-Jun-2008

Click
here to download Acrobat Reader
|
|
|
|
|
|
Copyright
© 1999-2005 Inspire Pharmaceuticals Inc. All rights reserved
|
|
|
|